• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新发心房颤动合并急性冠状动脉综合征。

Atrial fibrillation de novo in acute coronary syndrome.

机构信息

Servicio de Consulta Externa de Cardiología.

Servicio de Hospitalización de Cardiología.

出版信息

Arch Cardiol Mex. 2024;94(2):181-190. doi: 10.24875/ACM.23000008.

DOI:10.24875/ACM.23000008
PMID:38648718
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11160543/
Abstract

One of the complications during an acute coronary syndrome event is the presence of arrhythmias. Among them, those of the supraventricular type, especially atrial fibrillation, carry a poor prognosis both in the short and long term, being the cause of situations such as cerebrovascular event, ventricular arrhythmias, and increased mortality. The arrhythmia tends to appear in a certain population group with particular risk factors during the index event in approximately 10% of cases. Appropriate treatment at the time of its onset, thanks to the use of drugs that modulate heart rate, rhythm, and anticoagulant management in the most vulnerable groups, will lead to a less bleak outcome for these patients.

摘要

急性冠状动脉综合征事件期间的并发症之一是心律失常的存在。其中,室上性心律失常,尤其是心房颤动,在短期和长期预后都较差,是导致如脑血管事件、室性心律失常和死亡率增加等情况的原因。在大约 10%的情况下,这种心律失常会出现在指数事件中有特定危险因素的特定人群中。在其发生时,通过使用调节心率、节律的药物和对最脆弱人群的抗凝管理进行适当的治疗,将为这些患者带来不那么黯淡的结局。

相似文献

1
Atrial fibrillation de novo in acute coronary syndrome.新发心房颤动合并急性冠状动脉综合征。
Arch Cardiol Mex. 2024;94(2):181-190. doi: 10.24875/ACM.23000008.
2
New-onset or Pre-existing Atrial Fibrillation in Acute Coronary Syndromes: Two Distinct Phenomena With a Similar Prognosis.急性冠脉综合征中的新发或既往存在的心房颤动:两种不同现象,预后相似。
Rev Esp Cardiol (Engl Ed). 2019 May;72(5):383-391. doi: 10.1016/j.rec.2018.03.002. Epub 2018 Apr 10.
3
Impact of Acute Coronary Syndrome Complicated by Ventricular Fibrillation on Long-term Incidence of Sudden Cardiac Death.急性冠状动脉综合征并发心室颤动对心脏性猝死长期发生率的影响。
Rev Esp Cardiol (Engl Ed). 2015 Oct;68(10):878-84. doi: 10.1016/j.rec.2014.11.015. Epub 2015 Mar 21.
4
New-onset atrial fibrillation during acute coronary syndromes: predictors and prognosis.急性冠脉综合征期间新发房颤:预测因素与预后
Rev Port Cardiol. 2014 May;33(5):281-7. doi: 10.1016/j.repc.2013.10.017. Epub 2014 Jun 13.
5
Trends in atrial fibrillation in patients hospitalized with an acute coronary syndrome.急性冠状动脉综合征住院患者心房颤动的趋势。
Am J Med. 2012 Nov;125(11):1076-84. doi: 10.1016/j.amjmed.2012.05.024.
6
De novo and pre-existing atrial fibrillation in acute coronary syndromes: impact on prognosis and cardiovascular events in long-term follow-up.急性冠状动脉综合征中的新发和既往存在的心房颤动:对长期随访中预后和心血管事件的影响。
Eur Heart J Acute Cardiovasc Care. 2021 Dec 18;10(10):1129-1139. doi: 10.1093/ehjacc/zuab091.
7
Use of oral anticoagulants in complex clinical situations with atrial fibrillation.在伴有房颤的复杂临床情况下使用口服抗凝药物。
Med Clin (Barc). 2018 Jun;150 Suppl 1:8-24. doi: 10.1016/S0025-7753(18)30666-3.
8
[Is it necessary to prescribe oral anticoagulant therapy for paroxysmal atrial fibrillation during acute coronary syndrome, and for how long?].急性冠状动脉综合征期间阵发性心房颤动是否需要口服抗凝治疗,以及治疗多久?
G Ital Cardiol (Rome). 2019 Jun;20(6):361-366. doi: 10.1714/3165.31469.
9
Stroke-Heart Syndrome: Incidence and Clinical Outcomes of Cardiac Complications Following Stroke.卒中-心脏综合征:卒中后心脏并发症的发生率及临床结局
Stroke. 2022 May;53(5):1759-1763. doi: 10.1161/STROKEAHA.121.037316. Epub 2022 Mar 31.
10
Impact of known or new-onset atrial fibrillation on 2-year cardiovascular event rate in patients with acute coronary syndromes: results from the prospective EPICOR Registry.已知或新发心房颤动对急性冠状动脉综合征患者 2 年心血管事件发生率的影响:来自前瞻性 EPICOR 登记研究的结果。
Eur Heart J Acute Cardiovasc Care. 2019 Mar;8(2):121-129. doi: 10.1177/2048872618769057. Epub 2018 Apr 3.

引用本文的文献

1
Correlation between triglyceride-glucose index and atrial fibrillation in acute coronary syndrome patients: a retrospective cohort study and the establishment of a LASSO-Logistic regression model.急性冠状动脉综合征患者甘油三酯-葡萄糖指数与心房颤动的相关性:一项回顾性队列研究及LASSO-Logistic回归模型的建立
BMC Cardiovasc Disord. 2024 Dec 5;24(1):702. doi: 10.1186/s12872-024-04385-x.

本文引用的文献

1
Atrial Fibrillation Occurring During Acute Hospitalization: A Scientific Statement From the American Heart Association.急性住院期间发生的心房颤动:美国心脏协会科学声明
Circulation. 2023 Apr 11;147(15):e676-e698. doi: 10.1161/CIR.0000000000001133. Epub 2023 Mar 13.
2
Rotor mechanism and its mapping in atrial fibrillation.转子机制及其在心房颤动中的映射。
Europace. 2023 Mar 30;25(3):783-792. doi: 10.1093/europace/euad002.
3
Emerging molecular imaging targets and tools for myocardial fibrosis detection.新兴的心肌纤维化检测分子成像靶点及工具。
Eur Heart J Cardiovasc Imaging. 2023 Feb 17;24(3):261-275. doi: 10.1093/ehjci/jeac242.
4
Antithrombotic Therapy in Patients With Atrial Fibrillation After Acute Coronary Syndromes or Percutaneous Intervention.急性冠状动脉综合征或经皮介入治疗后心房颤动患者的抗血栓治疗。
J Am Coll Cardiol. 2022 Feb 8;79(5):417-427. doi: 10.1016/j.jacc.2021.11.035.
5
Cellular Senescence in Cardiovascular Diseases: A Systematic Review.心血管疾病中的细胞衰老:一项系统综述
Aging Dis. 2022 Feb 1;13(1):103-128. doi: 10.14336/AD.2021.0927. eCollection 2022 Feb.
6
2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients with Atrial Fibrillation.2021年欧洲心律协会心房颤动患者使用非维生素K拮抗剂口服抗凝药实用指南。
Europace. 2021 Oct 9;23(10):1612-1676. doi: 10.1093/europace/euab065.
7
Antithrombotic Therapy in Patients With Atrial Fibrillation Treated With Oral Anticoagulation Undergoing Percutaneous Coronary Intervention: A North American Perspective: 2021 Update.接受经皮冠状动脉介入治疗的口服抗凝治疗心房颤动患者的抗栓治疗:北美视角:2021年更新
Circulation. 2021 Feb 9;143(6):583-596. doi: 10.1161/CIRCULATIONAHA.120.050438. Epub 2021 Feb 8.
8
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC.2020年欧洲心脏病学会(ESC)与欧洲心胸外科学会(EACTS)合作制定的心房颤动诊断和管理指南:欧洲心脏病学会(ESC)心房颤动诊断和管理特别工作组,由ESC欧洲心律协会(EHRA)特别贡献制定。
Eur Heart J. 2021 Feb 1;42(5):373-498. doi: 10.1093/eurheartj/ehaa612.
9
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
10
Atrial fibrillation in acute coronary syndrome: patient characteristics and appropriate utilisation of anti-thrombotic therapy in New Zealand (ANZACS-QI 39).急性冠状动脉综合征中的心房颤动:新西兰患者特征及抗血栓治疗的合理应用(ANZACS-QI 39)
N Z Med J. 2020 Jul 31;133(1519):41-54.